Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $90,052 - $129,284
-1,445 Reduced 27.53%
3,803 $326,000
Q2 2022

Jul 19, 2022

SELL
$57.72 - $65.01 $454,371 - $511,758
-7,872 Reduced 60.0%
5,248 $324,000
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $851,225 - $966,156
13,120 New
13,120 $953,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Asset Allocation & Management Company, LLC Portfolio

Follow Asset Allocation & Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Allocation & Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Allocation & Management Company, LLC with notifications on news.